Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02029677 · ClinicalTrials.gov registry record
Appetite Suppression / Hormone Study Control Group
A clinical trial of Morbid Obesity and Bariatric Surgery Patient, sponsored by Oregon Weight Loss Surgery.
- Active
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT02029677: Active study of Morbid Obesity and Bariatric Surgery Patient, sponsored by Oregon Weight Loss Surgery.
NCT02029677 is a study of Morbid Obesity and Bariatric Surgery Patient that is active but no longer recruiting, run by Oregon Weight Loss Surgery. The registered enrollment target is 10 participants, below the 122-participant average among 24 other Morbid Obesity trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02029677, a study of Morbid Obesity and Bariatric Surgery Patient, is active but no longer recruiting, sponsored by Oregon Weight Loss Surgery.
- ACTIVE NOT RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine how changes in levels of obesity-related hormones in the gastrointestinal tract following Laparoscopic Adjustable Gastric Banding (LAGB) surgery may lead to a decrease in appetite and weight loss. Learning exactly how the Lap Band works may help us to develop new, less invasive treatments for morbid obesity. This knowledge may also lead to the development of preventive, cost-effective treatment strategies. As a control subject, participants will provide a comparison for changes in these hormones with medical weight loss compared to weight loss after LAGB surgery.
Conditions Studied
Study Locations (1)
Oregon
- Oregon Weight Loss Surgery - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-09 |
| Est. Completion | 2024-12 |
What the registry record for NCT02029677 still lists
NCT02029677 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 122-participant average among 24 other Morbid Obesity trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Morbid Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT02029677 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT02029677 about?
NCT02029677 is a clinical study titled "Appetite Suppression / Hormone Study Control Group". The purpose of this research study is to determine how changes in levels of obesity-related hormones in the gastrointestinal tract following Laparoscopic Adjustable Gastric Banding (LAGB) surgery may lead to a decrease in appetite and weight loss. Learning exactly how the Lap Band works may help us ...
What is the current status of trial NCT02029677?
This trial is currently active not recruiting. The enrollment target is 10 participants. The study started on 2008-09. Estimated completion is 2024-12.
What conditions does trial NCT02029677 study?
This clinical trial studies the following conditions: Morbid Obesity, Bariatric Surgery Patient.
Who is sponsoring clinical trial NCT02029677?
This trial is sponsored by Oregon Weight Loss Surgery, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02029677 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morbid Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02029677's enrollment target sits among peer trials
10 25th of 24 the lowest of 24 other Morbid Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Morbid Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Induction of Labor in Morbidly Obese Patients
RECRUITING · Early Phase 1
-
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
RECRUITING
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
-
Gut Microbiota in Metabolic Surgery
RECRUITING
-
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
RECRUITING · NA
-
Metabolic Responses to Bariatric Surgery
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia